Skip to content
Catalyst

CHEBI:15765Papers

Indexed under CHEBI:15765 in PubMed's chemical list

papers
62
32 years, by papers

Newest first

1 to 50 of 62
  • Association of serum homocysteine, folate, and vitamin B₁₂ levels with cognitive function in levodopa-naïve patients with Parkinson's disease and mild cognitive impairment.

    Neurologia i neurochirurgia polska2026PMID 42411114

  • Randomized, placebo-controlled trial of N-acetylcysteine in Parkinson's disease patients: a pilot study.

    Metabolic brain disease2026PMID 42776345

  • Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency.

    Journal of inherited metabolic disease2025PMID 41215497

  • Can we add whey protein supplementation in patients with Parkinson's disease without interfering with levodopa response?

    The International journal of neuroscience2024PMID 36786430Also indexed under CHEBI:15765 as a PubMed major topic

  • Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: OXYDOPA Trial.

    Movement disorders2024PMID 38850081Also indexed under CHEBI:15765 as a PubMed major topic

  • A systematic review of the potential consequences of abnormal serum levels of vitamin B6 in people living with Parkinson's disease.

    Journal of the neurological sciences2023PMID 37210937

  • Fucoxanthin Prevents Long-Term Administration l-DOPA-Induced Neurotoxicity through the ERK/JNK-c-Jun System in 6-OHDA-Lesioned Mice and PC12 Cells.

    Marine drugs2022PMID 35447917

  • Trial of Deferiprone in Parkinson's Disease.

    The New England journal of medicine2022PMID 36449420

  • Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota.

    Signal transduction and targeted therapy2021PMID 33623004

  • Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson's disease patients: A randomized controlled study.

    Journal of clinical neuroscience2021PMID 33992189

  • Parkinson's disease: Research puts spotlight on thiamine deficiency and cardiovascular health.

    Journal of clinical neuroscience2021PMID 34167881

  • The Effect of Caffeine on the Risk and Progression of Parkinson's Disease: A Meta-Analysis.

    Nutrients2020PMID 32580456

  • Neuroprotective effects of coenzyme Q10 on paraquat-induced Parkinson's disease in experimental animals.

    Behavioural pharmacology2018PMID 28902670

  • Hair in Parkinson's disease patients exhibits differences in Calcium, Iron and Zinc concentrations measured by flame atomic absorption spectrometry - FAAS.

    Journal of trace elements in medicine and biology2018PMID 29544800

  • Proposition of zinc supplementation during levodopa-carbidopa intestinal gel treatment.

    Brain and behavior2018PMID 30358126

  • Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.

    Neuroscience letters2017PMID 27840145

  • Caffeine consumption and the 4-year progression of de novo Parkinson's disease.

    Parkinsonism & related disorders2016PMID 27622969

  • Gabapentin versus levodopa-c for the treatment of restless legs syndrome in hemodialysis patients: a randomized clinical trial.

    Saudi journal of kidney diseases and transplantation2015PMID 25758874

  • Neuroprotective potential of Beta vulgaris L. in Parkinson's disease.

    Indian journal of pharmacology2015PMID 26288473

  • Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease.

    Sleep medicine2014PMID 24529544

  • Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over ("n-of-1") exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients.

    Parkinsonism & related disorders2013PMID 23283428

  • Caffeine consumption and risk of dyskinesia in CALM-PD.

    Movement disorders2013PMID 23339054

  • Effect of nicotine on the pharmacokinetics of levodopa.

    Clinical neuropharmacology2013PMID 23503546

  • Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical, glutamate and dopamine in the striatum of 6-OHDA-treated rats.

    Neurotoxicity research2012PMID 21830163

  • The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2.

    Neurotoxicity research2012PMID 22407500

  • Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke--a randomized, double-blind, placebo-controlled trial.

    Acta neurologica Scandinavica2011PMID 20569228

  • Balance control improves following replacement of paroxetine with venlafaxine and levodopa in a case of microvascular dementia.

    The American journal of geriatric pharmacotherapy2011PMID 21507731

  • Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial.

    European neurology2011PMID 21701174

  • Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies.

    Annals of the New York Academy of Sciences2010PMID 20201847

  • Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies.

    PloS one2010PMID 20700524

  • The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat.

    Psychopharmacology2009PMID 18791705

  • Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson's disease.

    Journal of neurology, neurosurgery, and psychiatry2009PMID 18977820

  • Cysteine elevation in levodopa-treated patients with Parkinson's disease.

    Movement disorders2009PMID 19243072

  • Long-term follow-up of Taiwanese Chinese patients treated early for 6-pyruvoyl-tetrahydropterin synthase deficiency.

    Archives of neurology2008PMID 18332253

  • Paradoxical effects of adenosine receptor ligands on hydroxyl radical generation by L-DOPA in the rat striatum.

    Pharmacological reports2008PMID 18622056

  • Motor changes during sertraline treatment in depressed patients with Parkinson's disease*.

    European journal of neurology2008PMID 18637826

  • Effects of amphetamine and/or L-dopa and physiotherapy after stroke - a blinded randomized study.

    Acta neurologica Scandinavica2007PMID 17156266

  • Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.

    Archives of neurology2007PMID 17353373

  • Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion.

    Journal of psychiatry & neuroscience2007PMID 17353942

  • A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities.

    Environmental research2007PMID 17445792

  • Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.

    Archives of neurology2007PMID 17502459

  • Dihydropteridine reductase deficiency: levodopa's long-term effectiveness without dyskinesia.

    Neurology2006PMID 17190955

  • Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression.

    Movement disorders2005PMID 15895421

  • Short-term paroxetine treatment does not alter the motor response to levodopa in PD.

    Neurology2005PMID 15911816

  • Low dose quetiapine for drug induced dyskinesias in Parkinson's disease: a double blind cross over study.

    Journal of neurology, neurosurgery, and psychiatry2004PMID 14742609

  • Quetiapine improves psychotic symptoms and cognition in Parkinson's disease.

    Movement disorders2004PMID 14743357

  • Effects of gabapentin on the motor response to levodopa: a double-blind, placebo-controlled, crossover study in patients with complicated Parkinson disease.

    Clinical neuropharmacology2004PMID 15190235

  • Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study.

    Renal failure2004PMID 15462107

  • Long-term outcome of quetiapine use for psychosis among Parkinsonian patients.

    Movement disorders2003PMID 12722164

  • Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.

    The Journal of clinical psychiatry2002PMID 12088163

The next 12 papers

Every paper about CHEBI:15765